However, a preclinical study carried out later with a larger sample size of two independent breast cancer populations including 438 tumor samples inferred that although EEF1A2 protein was detected in 60% of primary breast tumors, there was no significant correlation between EEF1A2 protein levels and ER positivity [18]. This evidence concerns the gene EEF1A2 and breast cancer.